Novartis sounds alarm on unsustainable drug supply chain if no-deal Brexit becomes reality
With the UK parliament no closer to finding a way to agree on a Brexit deal, the heightened prospect of a no-deal divorce has triggered Swiss drugmaker Novartis to urge Britain’s lawmakers to come up with a sustainable way to preserve the pharmaceutical supply chain, saying it has begun stockpiling so UK patients have undisturbed access to the 120 million packs of medicines the company makes for the region each year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.